miR‑146a‑5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression-Reference-Cited by-同舟云学术

miR‑146a‑5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression

Published:2019-02-25 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Huang Wen‑Ting¹,He Rong‑Quan²,Li Xiao‑Jiao³,Ma Jie⁴,Peng Zhi‑Gang⁴,Zhong Jin‑Cai⁴,Hu Xiao‑Hua⁴,Chen Gang⁵

Affiliation:

1. Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region�530021, P.R. China

2. Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region�530021, P.R. China

3. Department of PET‑CT, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region�530021, P.R. China

4. Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China

5. Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EMMPRIN promotes spheroid organization and metastatic formation: comparison between monolayers and spheroids of CT26 colon carcinoma cells;Frontiers in Immunology;2024-04-25

2. NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis;Journal of Hypertension;2024-02-20

3. MicroRNA-146a-5p induces cell cycle arrest and enhances apoptosis in gastric cancer via targeting CDC14A;Frontiers in Cell and Developmental Biology;2023-05-18

4. CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL;Leukemia;2022-06-08

5. SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer;BMC Medical Genomics;2022-05-17